This tumor-suppressing effect was attributed to the exopolysaccharides from Efm, which increased the percentage of IFN-γ+CD8+ T cells and synergized with sorafenib to induce ferroptosis in HCC cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.